Related references
Note: Only part of the references are listed.Studies in Zebrafish Demonstrate That CNNM2 and NT5C2 Are Most Likely the Causal Genes at the Blood Pressure-Associated Locus on Human Chromosome 10q24.32
Krishan K. Vishnolia et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
Evangelos Evangelou et al.
NATURE GENETICS (2018)
Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway
Catarina Rippe et al.
SCIENTIFIC REPORTS (2017)
Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants
Jana Wobst et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension
S. Wallace et al.
CLINICAL GENETICS (2016)
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction The SOCRATES-REDUCED Randomized Trial
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Role of sGC-dependent NO signalling and myocardial infarction risk
Jana Wobst et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
A multi-endpoint in vivo larval zebrafish (Danio rerio) model for the assessment of integrated cardiovascular function
Thomas Parker et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2014)
Dysfunctional nitric oxide signalling increases risk of myocardial infarction
Jeanette Erdmann et al.
NATURE (2013)
Large-scale association analysis identifies new risk loci for coronary artery disease
Panos Deloukas et al.
NATURE GENETICS (2013)
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Riociguat for the Treatment of Pulmonary Arterial Hypertension
Hossein-Ardeschir Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
Georg B. Ehret et al.
NATURE (2011)
Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease
Guido Boerrigter et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia
S John et al.
CURRENT HYPERTENSION REPORTS (2003)
Reactive oxygen species: Roles in blood pressure and kidney function
CS Wilcox
CURRENT HYPERTENSION REPORTS (2002)
Share Paper
